Selection and Management of Contract Vendors

Instructor: Peggy Berry
Product ID: 704884
Training Level: Intermediate
  • 18
  • November 2016
  • 10:00 AM PDT | 01:00 PM EDT
    Duration: 90 Min

Live Online Training
November 18, Friday 10:00 AM PDT | 01:00 PM EDT
Duration: 90 Min

One Dial-in One Attendee
Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days after completion of Live training

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

This webinar will discuss approaches to selecting vendors to perform manufacturing and testing activities as well as clinical study activities. The information obtained will enable implementation of an effective vendor selection program and a comprehensive vendor management and oversight program. The webinar will address aspects of requesting bids, performing audits, evaluating risks, and preparing plans and agreements for effective oversight and management.

Why Should You Attend:

GxPs are required to be followed, not only by the sponsoring company, but also by all vendors who are chosen by the company to complete activities that must follow GxPs. These vendors include, but are not limited to contract research organizations, clinical investigators, manufacturers of drug substance and drug product used in clinical studies and commercialized, labelers and distributors, testing laboratories, warehouses and so on.

In order to ensure selection of vendors who are appropriate to complete the job, companies must have in place a robust program for qualifying vendors, contracting with them, managing and overseeing their activities and a program for mitigating against risks that may arise related to key vendors.

This webinar will provide step-by-step considerations for finding potential vendors, implementing a robust qualification & selection process, strategies for oversight and management of vendors and a risk mitigation approach for key vendors.

Areas Covered in the Webinar:

  • Making a request for proposal to vendors
  • Performing evaluations of vendors
  • Auditing potential vendors
  • Evaluating business continuity of vendors for long-term relationships
  • Establishing comprehensive quality agreements
  • Strategy for development of communication plans and oversight activity reviews
  • Documenting and monitoring vendor activities
  • Value of evaluating back-up vendors

Who Will Benefit:

This presentation is targeted toward the following organizational positions and disciplines and is presented in practical language understandable by all technically educated or trained individuals, regardless of specialty. This information would be useful at levels from senior management to operative and would be valuable for experience levels ranging from seasoned veterans to those newly assigned to roles related to working with external vendors for GxP activities:

  • Quality Assurance
  • Quality Control
  • Manufacturing Operations
  • Validation
  • Clinical Operations
  • Project Management
  • Regulatory Affairs
  • Non-clinical Study Personnel
Instructor Profile:
Peggy Berry

Peggy Berry
Founder, Synergy Consulting LLC

Peggy J. Berry, MBA, RAC, is the president and CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics.

Prior to founding Synergy Consulting in 2015, she was vice president of regulatory affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was vice president of regulatory affairs and quality at Amarin (3/2009-2/2014). She has also held a variety of senior level positions at Dyax (5/2006-3/2009), MGI Pharma (now Eisai; 7/2005-5/2006), AstraZeneca (10/2001-7/2005), and Dey Pharma (now Mylan; 12/1997-10/2001). She has also held regulatory affairs roles within two clinical contract research organizations (ILEX Oncology and Cato Research Ltd; 1992-1997) and has worked in review divisions at the FDA (1985-1992).

In addition, Ms. Berry consults for a number of companies in the regulatory and quality area, conducts a number of training courses, and is active in the Regulatory Affairs Professionals Society. She is the editor of the 2010 book “Choosing the Right Regulatory Career” (RAPS, MD) and author of the 2011 book “Communication & Negotiation” (RAPS, MD).

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed